|
|
||||||||
1Department of Physiology, University of Munich, Munich; 2Max-Planck Institute for Biochemistry, Martinsried; 3Technical University of Munich, Munich; and 4Department of Clinical Chemistry and Clinical Biochemistry, University of Munich, Munich, Germany
Submitted 30 July 2004 ; accepted in final form 14 December 2005
The intracellular protease calpain, abundant in endothelial cells (EC), is assumed to be inactive under physiological conditions but may account for Ca2+-linked pathophysiological events. However, nonstimulated EC contained autolyzed, activated calpain. Adding 1248 µM calpain inhibitor I (CI) or 0.51 µM of the novel, membrane-permeable conjugate of calpastatin peptide-penetratin (CPP) caused rapid rounding and retraction of cultured EC (phase contrast, capacitance) and translocation of Syk, Rac, and Rho to the membrane, signifying activation upon inhibition of calpain. Isolated hearts (guinea pig) perfused with 12 µM CI or 0.5 µM CPP developed coronary leak. We conclude that calpain is constitutively active in EC and regulates vascular permeability by governing cell-cell attachment.
cell retraction; calpastatin; endothelium; coronary permeability; reperfusion
This article has been cited by other articles:
![]() |
T. Miyazaki, K. Honda, and H. Ohata m-Calpain antagonizes RhoA overactivation and endothelial barrier dysfunction under disturbed shear conditions Cardiovasc Res, October 7, 2009; (2009) cvp311v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain Diabetes, July 1, 2007; 56(7): 1842 - 1849. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |